EQR
54
-2
PPL
54
2
DE
46
3
STI
47
-12
DNB
78
6
ACN
47
-2
CSX
51
-2
UA
45
-3
MS
74
-2
PBI
60
-5
DD
56
3
ED
48
3
ETR
68
3
PVH
52
-3
QRVO
6
2
EXR
57
-2
EL
20
3
AIV
68
-4
CMCSA
48
2
TGNA
53
2
EQR
54
-2
PPL
54
2
DE
46
3
STI
47
-12
DNB
78
6
ACN
47
-2
CSX
51
-2
UA
45
-3
MS
74
-2
PBI
60
-5
DD
56
3
ED
48
3
ETR
68
3
PVH
52
-3
QRVO
6
2
EXR
57
-2
EL
20
3
AIV
68
-4
CMCSA
48
2
TGNA
53
2
Financhill
Back

Biodexa Pharmaceuticals PLC Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
20

BDRX
Biodexa Pharmaceuticals PLC

Last Price:
4.36
Seasonality Move:
-24.92%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Biodexa Pharmaceuticals PLC Price Quote

$4.36
+0.51 (+13.25%)
(Updated: November 21, 2024 at 5:55 PM ET)

Biodexa Pharmaceuticals PLC Key Stats

Sell
20
Biodexa Pharmaceuticals PLC (BDRX) is a Sell
Day range:
$3.51 - $3.85
52-week range:
$3.51 - $220.25
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
3.29
P/B ratio:
0.19%
Volume:
33K
Avg. volume:
327.5K
1-year change:
-94.28%
Market cap:
$2.1M
Revenue:
$474.1K
EPS:
$-74.6

How Much Does Biodexa Pharmaceuticals PLC Make?

Data Unavailable

Is Biodexa Pharmaceuticals PLC Growing As A Company?

Data Unavailable

Biodexa Pharmaceuticals PLC Stock Price Performance

What Is Biodexa Pharmaceuticals PLC 52-Week High & Low?

Biodexa Pharmaceuticals PLC Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Biodexa Pharmaceuticals PLC?

Is Biodexa Pharmaceuticals PLC Cash Flow Positive?

  • What Is BDRX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$9.7M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $10.8M
  • What Is Biodexa Pharmaceuticals PLC’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$1.3M

Biodexa Pharmaceuticals PLC Return On Invested Capital

Data Unavailable

Biodexa Pharmaceuticals PLC Earnings Date & Stock Price

Biodexa Pharmaceuticals PLC Competitors

Biodexa Pharmaceuticals PLC Dividend Yield

Biodexa Pharmaceuticals PLC Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 0%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.02
Upside from Last Price: 108.19%

Major Shareholders

  • How many BDRX shares are owned by institutional investors?
    160.4K BDRX shares are owned by institutional investors
  • How many BDRX shares are owned by insiders?
    1.3M BDRX shares are owned by insiders